[go: up one dir, main page]

MX2010003719A - Vacuna de mycoplasma bovis y metodos de uso de la misma. - Google Patents

Vacuna de mycoplasma bovis y metodos de uso de la misma.

Info

Publication number
MX2010003719A
MX2010003719A MX2010003719A MX2010003719A MX2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A MX 2010003719 A MX2010003719 A MX 2010003719A
Authority
MX
Mexico
Prior art keywords
mycoplasma bovis
bovis
bovis vaccine
present
bacteria
Prior art date
Application number
MX2010003719A
Other languages
English (en)
Inventor
Jeffrey KNITTEL
Michael Beck
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of MX2010003719A publication Critical patent/MX2010003719A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

La presente invenci?n se refiere a nuevas cepas bacterianas de M. bovis atenuadas. Adem?s, la presente invenci?n tambi?n proporciona composiciones inmunog?nicas que comprenden bacterias vivas de esas cepas de bacterias M. bovis atenuadas, su fabricaci?n y su uso para el tratamiento y profilaxis de infecciones por M. bovis.
MX2010003719A 2007-10-29 2008-10-29 Vacuna de mycoplasma bovis y metodos de uso de la misma. MX2010003719A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98348207P 2007-10-29 2007-10-29
US7555208P 2008-06-25 2008-06-25
PCT/US2008/081545 WO2009058833A2 (en) 2007-10-29 2008-10-29 Mycoplasma bovis vaccine

Publications (1)

Publication Number Publication Date
MX2010003719A true MX2010003719A (es) 2010-04-27

Family

ID=40591728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003719A MX2010003719A (es) 2007-10-29 2008-10-29 Vacuna de mycoplasma bovis y metodos de uso de la misma.

Country Status (14)

Country Link
US (1) US8652481B2 (es)
EP (1) EP2214702B1 (es)
JP (2) JP2011500093A (es)
KR (2) KR101656301B1 (es)
CN (2) CN101827605B (es)
AR (1) AR069087A1 (es)
BR (1) BRPI0819149B1 (es)
CA (1) CA2699218C (es)
CL (1) CL2008003202A1 (es)
MX (1) MX2010003719A (es)
NZ (1) NZ585588A (es)
SG (1) SG185932A1 (es)
UY (1) UY31437A1 (es)
WO (1) WO2009058833A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
US8503527B2 (en) 2008-10-03 2013-08-06 Qualcomm Incorporated Video coding with large macroblocks
KR20110089260A (ko) * 2008-10-31 2011-08-05 베링거잉겔하임베트메디카인코퍼레이티드 다가 백신 조성물에서 마이코플라즈마 보비스 유래의 항원을 포함하는 다양한 항원의 용도
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CA2896298C (en) 2012-12-28 2024-01-16 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
BR112015015199B1 (pt) * 2012-12-28 2022-09-06 Boehringer Ingelheim Vetmedica Gmbh Composição imunogênica compreendendo antígenos de micoplasma e uso
PT3334454T (pt) 2015-08-14 2022-12-20 Univ Melbourne Composições de mycoplasma bovis
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN107118262A (zh) * 2016-02-24 2017-09-01 华中农业大学 一种牛支原体MbovP579蛋白及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7007A (en) * 1850-01-08 Improvement in machinery for making cotton cordage
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
AU8296498A (en) * 1997-07-10 1999-02-08 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated
EP0965639A1 (en) 1998-06-05 1999-12-22 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP1165127B1 (en) * 1999-03-26 2008-12-31 Walter Reed Army Institute of Research Multivalent dengue virus vaccine
CA2390613A1 (en) 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1521592A2 (en) 2001-07-02 2005-04-13 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
EP1420636A2 (en) 2001-08-28 2004-05-26 Pfizer Products Inc. Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
DE102004025452A1 (de) 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
AU2009265092B2 (en) 2008-07-03 2015-09-03 Biotechnology Research And Development Corporation Cattle vaccines
KR20110089260A (ko) * 2008-10-31 2011-08-05 베링거잉겔하임베트메디카인코퍼레이티드 다가 백신 조성물에서 마이코플라즈마 보비스 유래의 항원을 포함하는 다양한 항원의 용도
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada

Also Published As

Publication number Publication date
EP2214702A4 (en) 2010-12-22
AR069087A1 (es) 2009-12-30
CN103667125A (zh) 2014-03-26
US8652481B2 (en) 2014-02-18
JP2013223511A (ja) 2013-10-31
UY31437A1 (es) 2009-05-29
CL2008003202A1 (es) 2009-11-27
BRPI0819149B1 (pt) 2021-11-23
SG185932A1 (en) 2012-12-28
AU2008318793A1 (en) 2009-05-07
KR20160095185A (ko) 2016-08-10
EP2214702B1 (en) 2018-07-04
WO2009058833A2 (en) 2009-05-07
JP5789897B2 (ja) 2015-10-07
CN101827605A (zh) 2010-09-08
NZ585588A (en) 2012-09-28
JP2011500093A (ja) 2011-01-06
WO2009058833A3 (en) 2009-06-18
US20090130148A1 (en) 2009-05-21
EP2214702A2 (en) 2010-08-11
CN101827605B (zh) 2016-05-04
BRPI0819149A2 (pt) 2020-08-25
CA2699218C (en) 2019-09-10
CA2699218A1 (en) 2009-05-07
KR101656301B1 (ko) 2016-09-12
KR20100084626A (ko) 2010-07-27

Similar Documents

Publication Publication Date Title
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
CL2011002852A1 (es) Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
BR112013000921A2 (pt) tratamento de infecções pulmonares pela administração de tobramicina por aerolização
EP4241851A3 (en) Immunogenic compositions
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
UA113399C2 (xx) Штам непатогенної грамнегативної бактерії та його застосування в дерматології
EP2538970A4 (en) TREATMENT OR PREVENTION OF INFECTION
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
MX2022003871A (es) Composiciones inmunogénicas.
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
MX2015005112A (es) Composicion inmunogenica contra la aeromonas hydrophila.
WO2020120716A8 (en) Compositions comprising bacterial strains
SG178936A1 (en) Compositions and methods for treating bacterial infections using ceftaroline
MX2012004282A (es) Composiciones farmaceuticas.
PH12012502253A1 (en) Oral care compositions and methods
IL299751A (en) Preparations and methods for disinfection, treatment and prevention of bacterial infections
BR112015011944A8 (pt) linhagem bacteriana atenuada estável, seus usos e método para sua geração, composição de vacina
TH135890A (th) วัคซีนเชื้อเป็นที่ได้รับการดัดแปรปรับปรุงของ Mycoplasma bovis, วิธีการผลิตวัคซีน เชื้อเป็นที่ได้รับการดัดแปรของ Mycoplasma bovis, วัคซีนรวม และวิธีการรักษา

Legal Events

Date Code Title Description
FG Grant or registration